Does USTEKINUMAB Cause Facet joint syndrome? 1,105 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,105 reports of Facet joint syndrome have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 1.3% of all adverse event reports for USTEKINUMAB.
1,105
Reports of Facet joint syndrome with USTEKINUMAB
1.3%
of all USTEKINUMAB reports
982
Deaths
1,001
Hospitalizations
How Dangerous Is Facet joint syndrome From USTEKINUMAB?
Of the 1,105 reports, 982 (88.9%) resulted in death, 1,001 (90.6%) required hospitalization, and 1,006 (91.0%) were considered life-threatening.
Is Facet joint syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 1,105 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Facet joint syndrome?
RITUXIMAB (1,497)
METHOTREXATE (1,483)
TOCILIZUMAB (1,467)
LEFLUNOMIDE (1,464)
DICLOFENAC (1,441)
ALENDRONATE (1,425)
SECUKINUMAB (1,420)
ABATACEPT (1,410)
ADALIMUMAB (1,377)
FOLIC ACID (1,346)
Which USTEKINUMAB Alternatives Have Lower Facet joint syndrome Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE